The reports and news about
Molina Healthcare (MOH) are predominantly positive, highlighting its financial performance and strategic actions. MOH has consistently
exceeded earnings and revenue expectations, with impressive results in Q1 and Q4 for 2024 and all of 2023. MOH's Q1 earnings beat is due to growing membership, while the full-year 2023 results report strong earnings growth. The company's stock has attracted attention, with a rising relative strength and is outpacing its medical peers. An intrinsic calculation proposes that the
stock is undervalued by 37%, and its fundamentals appear to be driving an uptrend in the stock. The company has also been under the spotlight for
winning state Medicaid contracts from New Mexico and Michigan. However, stocks have been sold: shares were offloaded by large stakeholders including Director Richard Schapiro and CFO Mark Keim. Despite this, reports assert that Molina's stocks are a solid choice, indicating bullish sentiment around the company.
Molina has successfully closed on several acquisitions, including Bright HealthCare's California Medicare Business and My Choice Wisconsin. Despite concerns around medical care ratios, Molina continues to display strong industry position and solid earnings estimate revisions.
Molina Healthcare MOH News Analytics from Wed, 14 Jun 2023 07:00:00 GMT to Sat, 18 May 2024 20:17:37 GMT -
Rating 8
- Innovation 5
- Information 7
- Rumor 3
